Skip to main content
Fig. 3 | BMC Immunology

Fig. 3

From: Characteristics of the specific humoral response in patients with advanced solid tumors after active immunotherapy with a VEGF vaccine, at different antigen doses and using two distinct adjuvants

Fig. 3

IgG (a), IgM (b) and IgA (c) specific antibody titers against human VEGF at week 13. Antibody titer at week 0 was subtracted from the antibody titer at week 13 (specific antibody titer). Horizontal bars represent the median values of specific antibody titer, which are shown for each group. Empty or filled symbols represent patients with positive or negative antibody samples at week 13, respectively

Back to article page